2008; Daub et al., 2008). Gygi's group looked at phosphorylation changes across the proteome in the mitotic and G 1 phases of the HeLa cell cycle, using stable isotope metabolic labeling to enable ...

Cancer continues to pose a substantial public health problem in Nigeria, characterized by rising rates of occurrence and ...

This valuable study provides insights into a key question in comparative neuroanatomy and development. The authors provide evidence of the role for a particular micro-RNA in regulating the development ...

The genome incorporation mechanism for LINE-1, the only autonomously active retrotransposon in humans, leverages the cell ...

The ability of mutations to cause cancer depends on how fast they force cells to divide, Sinai Health researchers have found.

Princess Margaret Cancer Center at University Health Network-led researchers constructed a detailed single-cell atlas of ...

Unrepresentative pre-clinical models contribute to poor translation of glioblastoma research. We present an ...

Today, May 2, 2025, the moon is 5 day old and is in the Waxing Crescent phase of its lunar cycle. It is 27% illuminated. Moon phase Date First Quarter April 4 Full Moon April 12 Third/Last Quarter ...

including one targeting BCMA in phase 1 and another targeting CD19 and CD20 due to start trials in 2023. That strategic-level deal, which is worth up to $6 billion, followed a five-year T cell ...

UCLA researchers have developed a groundbreaking graphene-protected catalyst that extends hydrogen fuel cell lifespans beyond ...

Rinvoq (upadacitinib) becomes the first oral JAK inhibitor approved by the FDA for the treatment of giant cell arteritis in adults, following robust data from the Phase III SELECT-GCA trial ...